pentobarbital will lower the extent or result of pimavanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Avoid coadministration if possible. Watch for minimized pimavanserin efficacy. A rise in pimavanserin dosage may be required.pentobarbital will decrease the level or result of fosamprenavir by influencing hepa